Notice: Undefined variable: npDcheckClassBgp in /home/myhealth/typo3/typo3_src-4.2.10_chaire_modif/index.php on line 17
myhealthywaist.org - Documentation Centre


Documentation Centre

 

 

  of 1008 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Subcutaneous adipose tissue metabolic function and insulin sensitivity in people with obesity. Diabetes. 2021;70:2225-2236 May 16, 2022 Subcutaneous adipose tissue metabolic function and insulin sensitivity in people with obesity. Diabetes. 2021;70:2225-2236 Koh HE, van Vliet S, Pietka TA, Meyer GA, Razani B, Laforest R, Gropler RJ, Mittendorfer B Key Publications
Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study. Diabetes Obes Metab. 2021;23 :2385-2394 April 26, 2022 Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study. Diabetes Obes Metab. 2021;23 :2385-2394 Gong Q, Zhang P, Wang J, Gregg EW, Cheng YJ, Li G, Bennett PH; Da Qing Diabetes Prevention Outcome Study Group Key Publications
Avocado consumption, abdominal adiposity, and oral glucose tolerance among persons with overweight and obesity. J Nutr. 2021;151:2513-2521 April 25, 2022 Avocado consumption, abdominal adiposity, and oral glucose tolerance among persons with overweight and obesity. J Nutr. 2021;151:2513-2521 Khan NA, Edwards CG, Thompson SV, Hannon BA, Burke SK, Walk ADM, Mackenzie RWA, Reeser GE, Fiese BH, Burd NA, Holscher HD Key Publications
Adipose tissue insulin resistance is longitudinally associated with adipose tissue dysfunction, circulating lipids, and dysglycemia: The PROMISE cohort. Diabetes Care. 2021;44:1682-1691 April 08, 2022 Adipose tissue insulin resistance is longitudinally associated with adipose tissue dysfunction, circulating lipids, and dysglycemia: The PROMISE cohort. Diabetes Care. 2021;44:1682-1691 Semnani-Azad Z, Connelly PW, Bazinet RP, Retnakaran R, Jenkins DJA, Harris SB, Zinman B, Hanley AJ Key Publications
Glycemic index, glycemic load, and cardiovascular disease and mortality. N Engl J Med. 2021;385:378-379 April 07, 2022 Glycemic index, glycemic load, and cardiovascular disease and mortality. N Engl J Med. 2021;385:378-379 Kanter M, Angadi S, Slavin J Key Publications
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol. 2021;17:484-495 April 06, 2022 Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol. 2021;17:484-495 Ferguson D, Finck BN Key Publications
100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat Med. 2021;27:1154-1164 April 05, 2022 100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat Med. 2021;27:1154-1164 Sims EK, Carr ALJ, Oram RA, DiMeglio LA, Evans-Molina C Key Publications
Insulin signaling in the heart. Am J Physiol Endocrinol Metab. 2021;321:E130-E145 April 05, 2022 Insulin signaling in the heart. Am J Physiol Endocrinol Metab. 2021;321:E130-E145 Abel ED Key Publications
Technology in the management of type 2 diabetes: Present status and future prospects. Diabetes Obes Metab. 2021;23:1722-1732 April 04, 2022 Technology in the management of type 2 diabetes: Present status and future prospects. Diabetes Obes Metab. 2021;23:1722-1732 Daly A, Hovorka R Key Publications
New USPSTF recommendations for screening for prediabetes and type 2 diabetes: An opportunity to create national momentum. JAMA. 2021;326:701-703 March 18, 2022 New USPSTF recommendations for screening for prediabetes and type 2 diabetes: An opportunity to create national momentum. JAMA. 2021;326:701-703 Gregg EW, Moin T Key Publications

  of 1008 Next page

Go to page: of